Naltrexone in the Treatment of Alcohol Dependence

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory

Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604

Survival Analysis

Miller, R. G. (1981) · Cited by 3,336

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541

Alteration of ethanol self-administration by naltrexone

Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397

The Effectiveness of Alcoholism Treatment

Miller, W. R., & Hester, R. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_7 · Cited by 276

The serotonin uptake inhibitor citalopram attenuates ethanol intake

Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236

Naltrexone blocks the post-shock increase of ethanol consumption

Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 187

Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey

Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 167

Lithium Treatment of Depressed and Nondepressed Alcoholics

Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164

Oral ethanol self-administration in the rat: Effect of naloxone

Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 162

Dancing with strangers

Rawson, R. A., Marinelli‐Casey, P., & Ling, W. W. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00292-7 · Cited by 25

Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users

Marks, K. R., Lile, J. A., Stoops, W. W., & Rush, C. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3449-x · Cited by 24

Trends in first-time treatment admissions for older adults with alcohol use disorder: Availability of medical and specialty clinical services in hospital, residential, and outpatient facilities

Huhn, A. S., Hobelmann, J. G., Ramirez, A., Strain, E. C., & Oyler, G. A. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107694 · Cited by 24

μ‐Opioid receptors mediate the effects of chronic ethanol binge drinking on the hippocampal neurogenic niche

Contet, C., Kim, A., Le, D., Iyengar, S. K., Kotzebue, R. W., Yuan, C. J., Kieffer, B. L., & Mandyam, C. D. (2013) · Addiction Biology · doi:10.1111/adb.12040 · Cited by 24

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent

AL-Eitan, L. N., Jaradat, S. A., Su, S., Tay, G. K., & Hulse (2012) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s33351 · Cited by 27

Voluntary Alcohol Drinking Enhances Proopiomelanocortin Gene Expression in Nucleus Accumbens Shell and Hypothalamus of S ardinian Alcohol‐Preferring Rats

Zhou, Y., Colombo, G., Niikura, K., Carai, M. A. M., Femenía, T., García‐Gutiérrez, M. S., Manzanares, J., Ho, A., Gessa, G. L., & Kreek, M. J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01867.x · Cited by 24

Measurement and choice of drinking outcome variables in the COMBINE Study.

Anton, R., & Randall, C. (2005) · Journal of Studies on Alcohol, Supplement · doi:10.15288/jsas.2005.s15.104 · Cited by 23

Balanced placebo design: Revolutionary impact on addictions research and theory

George, W. H., Gilmore, A. K., & Stappenbeck, C. A. (2012) · Addiction Research & Theory · doi:10.3109/16066359.2012.680216 · Cited by 29

Longitudinal Course of Substance Treatment Benefits in Older Male Veteran At-Risk Drinkers

Zanjani, F. A. K., Mavandadi, S., Tenhave, T., Katz, I. R., Durai, N. B., Krahn, D. D., Llorente, M. D., Kirchner, J. E., Olsen, E. J., Stone, W. V., et al. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.1.98 · Cited by 24

Alcohol addiction (alcoholism) and the opioid system

Terenius, L. Y. (1996) · Alcohol · doi:10.1016/0741-8329(95)02037-3 · Cited by 24

Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology

Grover, S., Bhateja, G., & Basu, D. (2007) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.31514 · Cited by 24

A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol

Workgroup, F. T. C.-D. M., Friedmann, P. D., Ducharme, L. J., Welsh, W. N., Frisman, L. K., Knight, K. K., Kinlock, T. W., Mitchell, S. G., Hall, E. A., Urbine, T. F., et al. (2013) · Health & Justice · doi:10.1186/2194-7899-1-6 · Cited by 24

The effect of ethanol drinking on opioid analgesia and receptors in mice

Shah, S., Duttaroy, A., Sehba, F. A., Chen, B., Philippe, J., Monderson, T., Lau‐Cam, C. A., Carroll, J. M., & Yoburn, B. C. (1997) · Alcohol · doi:10.1016/s0741-8329(96)00184-x · Cited by 24

Effect of Ethanol Self‐Administration on μ‐ and δ‐Opioid Receptor‐Mediated G‐Protein Activity

Sim‐Selley, L. J., Sharpe, A. L., Vogt, L. J., Brunk, L. K., Selley, D. E., & Samson, H. H. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02592.x · Cited by 24

Pharmacotherapy of Alcohol Use Disorders

Buonopane, A., & Petrakis, I. L. (2005) · Substance Use & Misuse · doi:10.1080/10826080500294890 · Cited by 24

Overview: The treatment of drug dependence

O’Brien, C. P. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03759.x · Cited by 24

Portacaval Anastomosis Induces Region–Selective Alterations of the Endogenous Opioid System in the Rat Brain

de Waele, J., Audet, R. M., Leong, D., & Butterworth, R. F. (1996) · Hepatology · doi:10.1002/hep.510240423 · Cited by 24

Tetrahydropapaveroline Injected in the Ventral Tegmental Area Shifts Dopamine Efflux Differentially in the Shell and Core of Nucleus Accumbens in High-Ethanol-Preferring (HEP) Rats

Myers, R. D., & Robinson, D. E. (1999) · Alcohol · doi:10.1016/s0741-8329(99)00008-7 · Cited by 24

Small sample longitudinal clinical trial with missing data: A comparison of analytic methods.

Delucchi, K., & Bostrom, A. (1999) · Psychological Methods · doi:10.1037/1082-989x.4.2.158 · Cited by 24

Evidence-Based Treatments of Addiction

O’Brien, C. P. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.1.foc107 · Cited by 24

Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review

Houghton, B., Kouimtsidis, C., Duka, T., Paloyelis, Y., & Bailey, A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15617 · Cited by 26

Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?

Antonelli, M., Sestito, L., Tarli, C., & Addolorato, G. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.016 · Cited by 23

Quetiapine for the treatment of alcoholism: Scientific rationale and review of the literature

Ray, L. A., Heydari, A., & Zorick, T. S. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00185.x · Cited by 24

Suppression de la dépendance à l’alcool et de la consommation d’alcool par le baclofène à haute dose : un essai en ouvert

Ameisen, O., & de Beaurepaire, R. (2010) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2009.12.008 · Cited by 23

Effects of the Atypical Antipsychotic Remoxipride on Alcohol Self-Administration

Files, F. J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00460-7 · Cited by 23

Influence of theOPRM1A118G Polymorphism on Alcohol-Induced Euphoria, Risk for Alcoholism and the Clinical Efficacy of Naltrexone

Setiawan, E., Pihl, R. O., Benkelfat, C., & Leyton, M. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.99 · Cited by 24

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

Kranzler, H. R., & Kirk, J. V. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200109000-00014 · Cited by 23

Sustained release drug delivery using supramolecular hydrogels of the triblock copolymer PCL–PEG–PCL and α-cyclodextrin

Tabassi, S. A. S., Tekie, F. M., Hadizadeh, F., Rashid, R., Khodaverdi, E., & Mohajeri, S. (2014) · Journal of Sol-Gel Science and Technology · doi:10.1007/s10971-013-3200-9 · Cited by 26

Screening, Assessment and Intervention for Substance use Disorders in General Health Care Settings

Fleming, M. F. (2002) · Substance Abuse · doi:10.1080/08897070209511507 · Cited by 22

Constituents of craving in a clinical alcohol sample

Westerberg, V. S. (2000) · Journal of Substance Abuse · doi:10.1016/s0899-3289(01)00051-7 · Cited by 23

Managing Alcohol Problems and Risky Drinking

Babor, T. F., Aguirre-Molina, M., Marlatt, G. A., & Clayton, R. (1999) · American Journal of Health Promotion · doi:10.4278/0890-1171-14.2.98 · Cited by 22

Cost effectiveness of disulfiram

Jofre‐Bonet, M., Sindelar, J. L., Petrakis, I. L., Nich, C., Frankforter, T. L., Rounsaville, B. J., & Carroll, K. M. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(04)00004-2 · Cited by 23

Reviews: Drug Abuse and Dependency: Understanding Gender Differences in Etiology and Management

Wasilow-Mueller, S., & Erickson, C. K. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31208-6 · Cited by 23

Effects of Naloxone on Limited‐Access Ethanol Drinking in Rats

Davidson, D., & Amit, Z. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01669.x · Cited by 23

Opiate and 5-HT2A receptors in alcohol drinking: Preference in had rats is inhibited by combination treatment with naltrexone and amperozide

Lankford, M. F., & Myers, R. D. (1996) · Alcohol · doi:10.1016/0741-8329(95)02011-x · Cited by 23

Neurotoxic Effect of Acamprosate, N-Acetyl-Homotaurine, in Cultured Neurons

Wu, J., Jin, H., Schloss, J. V., Faiman, M. D., Ningaraj, N. S., Foos, T., & Chen, W. (2001) · Journal of Biomedical Science · doi:10.1007/bf02255977 · Cited by 23

Pharmacotherapy of alcohol dependence

Zernig, G., Fabisch, K., & Fabisch, H. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01075-4 · Cited by 23

Conditioned Effects Produced by Naltrexone Doses That Reduce Ethanol‐Reinforced Responding in Rhesus Monkeys

Williams, K. L., & Woods, J. H. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04173.x · Cited by 23

Naltrexone for alcohol-dependent patients

Ahmadi, J., Babaeebeigi, M., Maany, I., Porter, J., Mohagheghzadeh, M., Ahmadi, N., & Dehbozorgi, G. (2004) · Irish Journal of Medical Science · doi:10.1007/bf02914522 · Cited by 22

Opioid Antagonists

Barnett, V., Twycross, R., Mihalyo, M., & Wilcock, A. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.12.223 · Cited by 22

IUPHAR Review: New strategies for medications to treat substance use disorders

Montoya, I. D., & Volkow, N. D. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107078 · Cited by 22

Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature

Lin, S. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12163 · Cited by 22

Hypothalamic‐specific proopiomelanocortin deficiency reduces alcohol drinking in male and female mice

Zhou, Y., Rubinstein, M., Low, M. J., & Kreek, M. J. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12362 · Cited by 22

A Novel and Selective Nociceptin Receptor ( NOP ) Agonist (1‐(1‐((cis)‐4‐isopropylcyclohexyl)piperidin‐4‐yl)‐1H‐indol‐2‐yl)methanol ( AT ‐312) Decreases Acquisition of Ethanol‐Induced Conditioned Place Preference in Mice

Zaveri, N. T., Marquez, P. V., Meyer, M. E., Polgar, W. E., Hamid, A., & Lutfy, K. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13575 · Cited by 22

Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders

Khoja, S., Huynh, N., Warnecke, A. M. P., Asatryan, L., Jakowec, M. W., & Davies, D. L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4869-9 · Cited by 22

Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats

Waeiss, R. A., Knight, C. P., Hauser, S. R., Pratt, L. A., McBride, W. J., & Rodd, Z. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5174-y · Cited by 22

Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future

Cannella, N., Ubaldi, M., Masi, A., Bramucci, M., Roberto, M., Bifone, A., & Ciccocioppo, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.014 · Cited by 24

Effects of naltrexone on the acquisition of alcohol intake in male and female periadolescent and adult alcohol-preferring (P) rats

Sable, H. J. K., Bell, R. L., Rodd, Z. A., & McBride, W. J. (2006) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh.2006.18.1.139 · Cited by 22

Effects of NMDA glutamate receptor antagonist drugs on the volitional consumption of ethanol by a genetic drinking rat

McMillen, B. A., Joyner, P., Parmar, C. A., Tyer, W. E., & Williams, H. L. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.08.001 · Cited by 22

Extended-Release Intramuscular Naltrexone

Harrison, T. S., Plosker, G. L., & Keam, S. J. (2006) · Drugs · doi:10.2165/00003495-200666130-00006 · Cited by 22

TOBACCO CESSATION WITH PATIENTS RECOVERING FROM ALCOHOL AND OTHER SUBSTANCE ABUSE

McIlvain, H. E., & Bobo, J. K. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70123-8 · Cited by 22

Infusion of brain‐derived neurotrophic factor into the ventral tegmental area switches the substrates mediating ethanol motivation

Ting‐A‐Kee, R. A., Vargas-Pérez, H., Bufalino, M. R., Bahí, A., Dreyer, J., Tyndale, R. F., & van der Kooy, D. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12105 · Cited by 22

The neurobiology of alcoholism in genetically selected rat models.

Stewart, R. B., & Li, T. (1997) · PubMed Central · Cited by 22

Effects of naltrexone on cortisol levels in heavy drinkers

Ray, L. A., MacKillop, J. M., Leggio, L., Morgan, M., & Hutchison, K. E. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.004 · Cited by 23

Rational treatment of addiction

Terenius, L. Y. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80132-4 · Cited by 22

Tolerability of Naltrexone in Treating Older, Alcohol-Dependent Patients

Oslin, D. W., Liberto, J. G., O’Brien, J. F., & Krois, S. (1997) · American Journal on Addictions · doi:10.1111/j.1521-0391.1997.tb00406.x · Cited by 22

Pharmacotherapy for Alcohol-Related Disorders: What Clinicians Should Know

Mariani, J. J., & LEVIN, F. R. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490905697 · Cited by 22

Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats

Perfumi, M. C., Mattioli, L., Cucculelli, M., & Massi, M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105056519 · Cited by 22

Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes

Wang, X., Douglas, S. D., Peng, J., Metzger, D. S., O’Brien, C. P., Zhang, T., & Ho, W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105642 · Cited by 22

Naltrexone for alcoholic adolescents

Lifrak, P., Alterman, A. I., O’Brien, C. P., & Volpicelli, J. R. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.439b · Cited by 22

Psychotic mania associated with fenfluramine and phentermine use

Raison, C. L., & Klein, H. M. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.711a · Cited by 22

Interactions Between Alcohol- and Opioid-Induced Suppression of Rat Testicular Steroidogenesis In Vivo

Adams, M. L., Meyer, E. R., & Cicero, T. J. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199706000-00020 · Cited by 22

The treatment of alcoholism in France

Batel, P. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01169-y · Cited by 22

A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence

Johnson, B. A. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1065 · Cited by 22

Intrapleural streptokinase for pleural infection

Bouros, D. E., Antoniou, K. M., & Light, R. W. (2006) · BMJ · doi:10.1136/bmj.332.7534.133 · Cited by 22

The effects of naltrexone among alcohol non-abstainers: results from the COMBINE study

Ray, L. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00026 · Cited by 21

The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder

Margolis, E. B., Moulton, M. G., Lambeth, P. S., & O’Meara, M. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109376 · Cited by 23

Drug abuse, innate immunity and hepatitis C virus

Zhang, T., Li, Y., & Ho, W. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.508 · Cited by 20

Exposure to low and moderate doses of alcohol on late gestation modifies infantile response to and preference for alcohol in rats.

Chotro, M. G., & Arias, C. (2006) · PubMed · Cited by 21

Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone

Zhou, Y., Crowley, R. S., Ben, K. T., Prisinzano, T. E., & Kreek, M. J. (2017) · Brain Research · doi:10.1016/j.brainres.2017.02.027 · Cited by 22

Naltrexone Acutely Enhances Connectivity Between the Ventromedial Prefrontal Cortex and a Left Frontoparietal Network

Elton, A., Dove, S., Spencer, C. N., Robinson, D. L., & Boettiger, C. A. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13999 · Cited by 20

Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual

Blum, K., Lott, L., Baron, D. A., Smith, D. E., Badgaiyan, R. D., & Gold, M. S. (2020) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000229 · Cited by 21

In Vitro Release Studies on Matrix Type Transdermal Drug Delivery Systems of Naltrexone and Its Acetyl Prodrug

Nalluri, B. N., Milligan, C., Chen, J., Crooks, P. A., & Stinchcomb, A. L. (2005) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500271944 · Cited by 21

Current and Future Drug Therapies for Alcohol Dependence

Rosenthal, R. N. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.000246223.94119.cd · Cited by 21

Naturalistic Follow-Up of Drinking Behavior Following Participation in an Alcohol Administration Study

Sinha, R., Krishnan‐Sarin, S., Farren, C. K., & O’Malley, S. S. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00058-0 · Cited by 21

Involvement of kappa-Opioids in the Mouse Cerebellar Adenosinergic Modulation of Ethanol-Induced Motor Incoordination

Dar, M. S. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199804000-00022 · Cited by 21

Distribution of opioid peptide gene expression in the limbic system of Fawn-Hooded (alcohol-preferring) and Wistar-Kyoto (alcohol-non-preferring) rats

Cowen, M. S., Rezvani, A. H., Jarrott, B., & Lawrence, A. J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00432-6 · Cited by 21

NALTREXONE FOR ALCOHOL ABUSE

Wold, M., & Kaminer, Y. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00010 · Cited by 21

Pharmacotherapy of Nicotine Dependence

Hughes, J. R. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_16 · Cited by 21

Psychoactive Substance Use Disorders

Greenfield, S. F., Weiss, R. D., & Mirin, S. M. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5877-4_7 · Cited by 21

The Role of cAMP in Ethanol‐Regulated β‐Endorphin Release from Hypothalamic Neurons

Boyadjieva, N. I., & Sarkar, D. K. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03829.x · Cited by 21

New treatment options for substance abuse from a public health viewpoint

Sinclair, J. D. (1998) · Annals of Medicine · doi:10.3109/07853899809029941 · Cited by 21

The Black Book of Psychotropic Dosing and Monitoring

DeBattista, C., & Schatzberg, A. F. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4493 · Cited by 23

Substance Use Disorder

Swimmer, K. R., & Sandelich, S. (2023) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2023.06.023 · Cited by 20

A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence

Pettinati, H. M., Kampman, K. M., Lynch, K. G., Dundon, W. D., Mahoney, E. M., Wierzbicki, M. R., & O’Brien, C. P. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12146.x · Cited by 19

Food–alcohol competition: As young females eat more food, do they drink less alcohol?

Cummings, J. R., Ray, L. A., & Tomiyama, A. J. (2015) · Journal of Health Psychology · doi:10.1177/1359105315611955 · Cited by 21

A Study of the Reliability and Validity of the Korean Version of the Penn Alcohol Craving Scale for Alcohol-Dependent Patients

Kim, M. J., Kim, S. G., Kim, H. J., Kim, H. C., Park, J. H., Park, K. S., Lee, D. K., Byun, W. T., & Kim, C. M. (2008) · Psychiatry Investigation · doi:10.4306/pi.2008.5.3.175 · Cited by 20

Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder

Karl, D., Bumb, J. M., Bach, P., Dinter, C., Koopmann, A., Hermann, D., Mann, K. F., Kiefer, F., & Vollstädt‐Klein, S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05842-7 · Cited by 20

Gene expression and activity of specific opioid-degrading enzymes in different brain regions of the AA and ANA lines of rats

Winkler, A., Rottmann, M., Heder, G., Hyytiä, P., Siems, W., & Melzig, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00041-0 · Cited by 20

A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients

Guardia, J., Roncero, C., Galan, J. L., Gonzalvo, B., Burguete, T., & Casas, M. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.11.006 · Cited by 20

Selective d‐opioid receptor antagonist N,N(CH 3) 2 ‐Dmt‐Tic‐OH does not reduce ethanol intake in alcohol‐preferring AA rats

Ingman, K., Salvadori, S., Lazarus, L. H., Korpi, E. R., & Honkanen, A. (2003) · Addiction Biology · doi:10.1080/1355621031000117400 · Cited by 20

Naloxone retards the expression of a genetic predisposition toward alcohol drinking

Badia‐Elder, N. E., Mosemiller, A. K., Elder, R. L., & Froehlich, J. C. (1999) · Psychopharmacology · doi:10.1007/s002130050995 · Cited by 20

Extended naltrexone and broad spectrum treatment or motivational enhancement therapy

Longabaugh, R., Wirtz, P. W., Gulliver, S. B., & Davidson, D. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1615-3 · Cited by 20

Morphine enhances selection of both sucrose and ethanol in a two-bottle test

Stromberg, M. F., Meister, S. C., Volpicelli, J. R., & Ulm, R. R. (1997) · Alcohol · doi:10.1016/s0741-8329(96)00107-3 · Cited by 20

Genetic differences in naloxone enhancement of ethanol-induced conditioned taste aversion

Broadbent, J., Linder, H. V., & Cunningham, C. L. (1996) · Psychopharmacology · doi:10.1007/bf02246350 · Cited by 20

Alcoholism and Substance Abuse

Warne, D. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00065-0 · Cited by 20

6‐β‐Naltrexol Reduces Alcohol Consumption in Rats

Rukstalis, M. R., Stromberg, M. F., O’Brien, C. P., & Volpicelli, J. R. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04580.x · Cited by 20

Consumers Of Mental Health Services

Roy, A. (2001) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.31.1.5.60.24222 · Cited by 18

Pharmacotherapy for alcohol use disorder.

Holt, S. R., & Tobin, D. G. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.008 · Cited by 17

Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme

Feeney, G. F. X., Connor, J. P., Young, R. M., Tucker, J., & Czajkowski, F. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00326.x · Cited by 13

A double‐blind, placebo‐controlled study of naltrexone in the treatment of alcohol dependence in Taiwan

Huang, M., Chen, C.-Y. O., Yu, J., & Chen, C. (2005) · Addiction Biology · doi:10.1080/13556210500223504 · Cited by 39

Naltrexone in the treatment of alcoholism: A clinical review

O’Brien, C. P., Volpicelli‐Daley, L. A., & Volpicelli, J. R. (1996) · Alcohol · doi:10.1016/0741-8329(95)02038-1 · Cited by 189

Naltrexone for alcohol dependence: a randomized controlled trial

Morris, P., Hopwood, M., Whelan, G., Gardiner, J., & Drummond, E. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961115654.x · Cited by 200

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting

Latt, N. C., Jurd, S. M., Houseman, J., & Wutzke, S. E. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04550.x · Cited by 128

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.

Guardia, J., Caso, C., Árias, F., Gual, A., Sanahuja, J., Ramírez, M., Mengual, I., Gonzalvo, B., Segura, L., Trujols, J., et al. (2002) · PubMed · doi:10.1097/01.alc.0000030561.15921.a9 · Cited by 117